Group 1 - Fuda Alloy's controlling shareholder Wang Dawu plans to reduce his stake by up to 3% of the company's total shares, amounting to a maximum of 406.34 million shares, due to personal funding needs [1] - ST Songfa's subsidiary signed contracts for the construction of 17 vessels, with a total contract value between 1.6 billion to 1.8 billion USD [2] - Pairui Co. signed a technical cooperation agreement with a university to develop large-capacity power semiconductor devices and related power electronic modules, effective for three years [3] Group 2 - Shuangliang Energy indirectly participates in commercial aerospace projects, supplying heat exchangers for SpaceX's fuel production system, with orders totaling approximately 1.39 million CNY [4] - Hangya Technology plans to issue convertible bonds to raise up to 600 million CNY for various projects, including an intelligent manufacturing base in Malaysia [5] - Yuhua Development is publicly selling assets with a base price of 251 million CNY for residential properties [6] Group 3 - Penghui Energy plans to invest 2.1 billion CNY in a new battery production project in Zhengyang County, Henan Province, focusing on high-performance battery products [7] - Haige Communication's shareholder Yang Haizhou intends to reduce his stake by up to 0.1624% of the company's total shares [8] - Yaoshi Technology's controlling shareholder pledged 5.13% of shares to repay loans, with a pledge period from February 10, 2026, to February 2, 2027 [9][10] Group 4 - Hanyu Pharmaceutical received FDA approval for its drug Acetate Glatiramer Injection, used for treating relapsing multiple sclerosis [11] - Baiyao Tai's GoliMab Injection received EMA approval for various indications, including rheumatoid arthritis and ulcerative colitis [12] - Jiangxi Tungsten Equipment plans to issue A-shares to raise up to 1.882 billion CNY for acquisitions [13] Group 5 - Hesong New Materials expects to recognize asset impairment provisions between 23.6 million to 28.5 million CNY for 2025 [14] - ST Meichen's subsidiary is involved in two major lawsuits with a total amount of approximately 31.9 million CNY [15] - China Coal Energy reported a 7.3% year-on-year decline in coal sales for January 2026, with total sales of 20.05 million tons [16] Group 6 - Yida Co. plans to adjust its epoxy propylene derivative project, reducing the total investment from 845 million CNY to 642 million CNY [17] - Fosun Pharma's subsidiary received approval for a clinical trial of HLX15-SC for multiple myeloma treatment [18][19] - Yinfeng Communication's board members and executives have terminated their share reduction plan [20] Group 7 - Huazhong High-tech has waived its preferential purchase rights for a fund, extending the investment period from three to four years [21] - Warner Pharmaceuticals plans to participate in a national drug procurement program, with expected sales of 176 million CNY [22] - Changling Hydraulic announced a tender offer to acquire 12% of its shares at a price of 35.82 CNY per share [23] Group 8 - ST Chuan Zhi's stock may face delisting due to financial data falling below regulatory thresholds [24] - Tian Pharmaceutical and its subsidiaries are participating in a national drug procurement program, with expected sales of 323 million CNY [25] - China Metallurgical Group signed new contracts worth 73.65 billion CNY in January 2026 [26] Group 9 - Torus plans to invest 21.2 million CNY in a venture capital fund focused on artificial intelligence [27] - Shangwei Co. received a government subsidy of 1.764 million CNY, representing 10.79% of its net profit for 2024 [28] - Hanghua Co. reported a 21.97% decline in net profit for 2025, with total revenue of 1.249 billion CNY [29] Group 10 - Huaxia Bank reported a 1.72% decline in net profit for 2025, with total revenue of 91.914 billion CNY [30] - Guotou Fengle plans to transfer 51% of its stake in Hubei Fengle Ecological Fertilizer to optimize management [31] - Huaru Technology is co-investing in a fund with a total commitment of 20 million CNY [32] Group 11 - Jindike reported a loss of 173 million CNY for 2025, despite a 40.13% increase in revenue [33] - Zhenong Co. announced a 0.52% increase in shares held by a major shareholder [34] - Maike Audi plans to recognize asset impairment provisions of approximately 52.55 million CNY [35] Group 12 - Fuan Pharmaceutical's subsidiary is expected to be selected for a national drug procurement program, with projected sales of 680 million CNY [36] - Rundu Co. is participating in a national drug procurement program, with some products expected to be selected [37] - Changqing Co. has postponed its large-scale die-casting project to March 2027 due to customer requirements [38] Group 13 - Pan Asia Micro透 received a patent for a graphene-based automotive headlight defogging device [39] - Luan An Huan Neng reported a 17.1% increase in raw coal production for January 2026, totaling 5 million tons [40] - Guangji Pharmaceutical received a drug registration certificate for Mecobalamin Tablets [41] Group 14 - Ruifeng New Materials announced the resignation of its deputy general manager for personal reasons [42] - Zhiguang Electric's subsidiary signed a procurement contract for energy storage equipment worth 210.4 million CNY [43] - Youyan Powder Materials reported a 19.41% increase in net profit for 2025 [44] Group 15 - Jincheng reported a 22.2% increase in net profit for 2025, with total revenue of 253 million CNY [46]

Core Viewpoint - Tungsten, known as "industrial teeth," is experiencing a surge in demand and price due to supply constraints and strong market demand [1][2]. Group 1: Price Increases - The long-term procurement prices for tungsten products have significantly increased, with 55% black tungsten concentrate rising by 28.1% to 670,000 CNY/ton and 55% white tungsten concentrate increasing by 28.2% to 669,000 CNY/ton [2][3]. - Ammonium paratungstate (standard grade zero) long-term procurement price rose by 27.6% to 970,000 CNY/ton [2]. Group 2: Supply and Demand Dynamics - Domestic mining operations are conservatively producing, leading to a weak market increment expectation and further price adjustments for long-term contracts [2]. - The supply side is facing tightening due to stricter safety and environmental regulations, resulting in decreased production and shipments from some mines [2][3]. - Demand remains stable, primarily driven by essential purchases, particularly in the PCB tool sector [2]. Group 3: Future Price Outlook - Institutions are optimistic about the future price of tungsten, with expectations for continued strong performance and new highs [3]. - The global tungsten production is projected to increase from 82,800 tons in 2025 to 89,900 tons by 2028, while demand is expected to rise from 102,100 tons to 110,000 tons, indicating a potential supply-demand gap [3]. Group 4: Stock Market Response - A-share tungsten concept stocks have reacted positively to the price increases and supply-demand changes, with several stocks hitting the daily limit [4]. - Notable performers include Xianglu Tungsten Industry and Zhangyuan Tungsten Industry, both of which saw significant price increases [4][5]. - Xianglu Tungsten Industry has achieved a cumulative increase of 166.32% this year, reflecting strong market interest [5].

证券代码：600397 证券简称：江钨装备 公告编号：2026-019 江西江钨稀贵装备股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●江西江钨稀贵装备股份有限公司（以下简称"公司"）股票于 2026 年 2 月 10 日、 2 月 11 日、2 月 12 日连续 3 个交易日内收盘价格涨幅偏离值累计达到 20%，根据《上海 证券交易所交易规则》的有关规定，属于股票交易异常波动情形。 ●公司正在筹划 2026 年度向特定对象发行 A 股股票事项，并于 2026 年 2 月 12 日 在上海证券交易所网站（www.sse.com.cn）发布了《江西江钨稀贵装备股份有限公司关 于 2026 年度向特定对象发行 A 股股票预案披露的提示性公告》（公告编号：2026-011）。 本次向特定对象发行 A 股股票事项尚需募集资金投资项目有关审计、评估等工作完成后 再次召开董事会审议通过、公司股东会审议通过、获得有权国资审批单位批准、经上海 证券交易所审核通过并报中国证监会同意注册后方可 ...

江西钨业控股集团有限公司 关于对江钨装备股票交易异常波动情况 核查的回复函 江西江钨稀贵装备股份有限公司: 你公司《关于对江钨装备股票交易异常波动情况核查的 问询函》收悉,经核查,回复如下: 关于对江钨装备股票交易异常波动情况 核查的复函 江西钨业控股集团有限公司: 你公司《关于对江钨装备股票交易异常波动情况核查的间询 函》收悉,经核查,回复如下: 1.除江钨装备已披露的关于 2026年度向特定对象发行 A 股 股票的重大事项外,截至目前,我公司不存在关于江钨装备相关 的应披露而未披露的重大信息,包括但不限于重大资产重组、股 份发行、重大交易类事项、业务重组、股份回购、股权激励、破 产重整、重大业务合作、引进战略投资者等重大事项。 2.本次股票交易异常波动期间,我公司未发生违规买卖江钨 装备股票的行为。 特此回复。 江市 1. 除你公司已披露的关于 2026年度向特定对象发行 A 股股票的重大事项外,截至目前,我公司不存在关于江钨装 备相关的应披露而未披露的重大信息,包括但不限于筹划与 江钨装备相关的重大资产重组、股份发行、重大交易类事项、 业务重组、股份回购、股权激励、破产重整、重大业务合作、 引进战略投资 ...

Core Viewpoint - Jiangxi Tungsten Equipment announced that its stock price experienced a cumulative deviation of 20% over three consecutive trading days, indicating abnormal trading activity [1] Group 1: Stock Trading Activity - The stock price deviation occurred on February 10, 11, and 12, 2026, leading to the classification of the situation as an abnormal fluctuation according to Shanghai Stock Exchange rules [1] - The company conducted a self-examination and inquired with its major shareholders, confirming no undisclosed significant information that could affect stock trading [1] Group 2: Company Operations - The company stated that its production and operational activities are normal, with no significant changes in its main business or external operating environment [1] - There have been no media reports, market rumors, or trending concepts identified that could influence the company's stock price [1] Group 3: Shareholder Activities - The company confirmed that its directors, senior management, and major shareholders are not involved in any illegal trading of the company's stock [1]

Core Viewpoint - Jiangxi Tungsten Equipment (江钨装备) has announced a plan to issue A-shares to raise up to 1.88 billion yuan for acquiring 100% stakes in three companies: Jiangxi Jiangtung Hard Alloy Co., Ltd., Ganzhou Huamao Tungsten Materials Co., Ltd., and Jiujiang Nonferrous Metal Smelting Co., Ltd. The stock price surged by 9.99% to 14.31 yuan following the announcement [1][2]. Group 1: Fundraising and Acquisition Details - The total amount to be raised from the issuance is capped at 188,195.26 million yuan, which will be used entirely for the acquisitions [2]. - The specific investments include 87,038 million yuan for Jianghard Company, 71,701.19 million yuan for Huamao Company, and 29,456.07 million yuan for Jiujiang Company [2]. - The shares will be issued to no more than 35 specific investors, including the controlling shareholder Jiang Tung Holdings, which plans to acquire between 20% and 40% of the issued shares [3][4]. Group 2: Share Issuance and Control - The issuance will not exceed 30% of the company's total shares prior to the issuance, amounting to a maximum of 296,987,964 shares [4][5]. - Jiang Tung Holdings, as the controlling shareholder, will have a lock-up period of 18 months post-issuance, ensuring that control remains unchanged [4][6]. - The issuance will be conducted through a competitive bidding process, with the price set at no less than 80% of the average trading price over the previous 20 trading days [3]. Group 3: Financial Performance of Target Companies - Jianghard Company reported total assets of 160,569.67 million yuan and a net profit of 3,140.05 million yuan for the year ending December 31, 2025, showing significant growth from the previous year [7]. - Huamao Company had total assets of 199,810.53 million yuan and a net profit of 5,930.24 million yuan for the same period, indicating a recovery from a loss in the previous year [8]. - Jiujiang Company’s financial data was not provided in the excerpts, but it is included in the acquisition plan [6].

Group 1: Major Announcements - Unisplendour plans to raise no more than 5.57 billion yuan through a private placement to acquire a 6.98% stake in New H3C and for other projects [2] - Zhongwei Semiconductor intends to establish an IPM production line project in Ziyang, Sichuan, using 1.21 billion yuan of leftover IPO funds [2] - Kaiying Network has signed a settlement agreement with Legend IP, which is expected to positively impact the company's profit by approximately 200 million yuan [2] Group 2: Project Developments - Blue Ocean Huaten plans to invest 8 million yuan in Wanren Technology to support its daily operations and AI project development [4] - Yuedian Power A has successfully put into operation the expansion project of the Huizhou Power Plant, which includes two 1000MW units [7] - Longmag Technology intends to raise up to 760 million yuan for its second phase project in Vietnam and chip inductor manufacturing [8] Group 3: Financial Performance - Top Group expects a net profit of 2.6 billion to 2.9 billion yuan for 2025, a decrease of 3.35% to 13.35% year-on-year due to rising raw material costs and increased market competition [20] - Jingchen Technology reported a net profit of 871 million yuan for 2025, a 6% increase year-on-year, with record high sales of over 174 million chips [21] - Guodian Xintong's net profit for 2025 is projected at 678 million yuan, a decline of 16.91% year-on-year, primarily due to increased credit impairment losses and tax expenses [22] Group 4: Shareholder Actions - Jieshun Technology's actual controller plans to reduce holdings by up to 2.8% of the company's shares [27] - Lihexing's controlling shareholder and concerted actors plan to collectively reduce their holdings by up to 1% [27] - Kory Technology's shareholders plan to reduce their holdings by a total of up to 3.13% [29] Group 5: Stock Buybacks - Quzhou Dongfeng plans to repurchase shares worth between 50 million and 100 million yuan, with a maximum price of 6.48 yuan per share [30]

江钨装备（600397）(600397.SH)披露向特定对象发行A股股票预案，发行对象为包括公司控股股东江钨 控股在内的不超过35名(含35名)符合中国证监会规定条件的特定投资者。本次发行募集资金总额(含发行 费用)不超过18.82亿元，扣除发行费用后将用于：收购江硬公司100%股权、收购华茂公司100%股权、 收购九冶公司100%股权。 ...

智通财经APP讯，江钨装备(600397.SH)披露向特定对象发行A股股票预案，发行对象为包括公司控股股 东江钨控股在内的不超过35名(含35名)符合中国证监会规定条件的特定投资者。本次发行募集资金总额 (含发行费用)不超过18.82亿元，扣除发行费用后将用于：收购江硬公司100%股权、收购华茂公司100% 股权、收购九冶公司100%股权。 ...

格隆汇2月11日丨江钨装备(600397.SH)公布，本次发行募集资金总额（含发行费用）不超过18.82亿元， 扣除发行费用后将用于以下项目：收购江硬公司100%股权、收购华茂公司100%股权、收购九冶公司 100%股权。 ...